This developer of single-use medical devices for use in minimally invasive cardiovascular procedures has seen 6 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Spectranetics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some other notable stocks in the same industry are Rofin-Sinar Technologies Inc. (RSTI), IPG Photonics Corporation (IPGP) and Microvision Inc. (MVIS). All the three stocks carry the same Zacks Rank as Spectranetics.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment